Plant cells may help cure hemophilia

Treating hemophilia, a rare bleeding disorder in which the blood does not clot normally, could be a lot cheaper and much safer as researchers have developed a way to use plant cells to treat it.
Patients with hemophilia bleed for a longer time than others after an injury as they lack the necessary proteins, which help in clotting, in their blood to stem the flow from a wound.
People with severe hemophilia typically receive regular injections of these proteins, called clotting factors, as a treatment for the disease.
But up to 30 percent of people afflicted with the most common form, hemophilia A, develop antibodies (inhibitors) that attack these lifesaving proteins, making it difficult to prevent or treat excessive bleeding.
Henry Daniell from the University Of Pennsylvania School Of Dental Medicine in US and researcher declared that the plant cell based capsules are cost effective and alternative treatment for the hemophilia.
The researchers had developed a platform for delivering drugs and bio-therapeutics using genetically modified plants to express proteins.
The study appeared in the journal Blood.